Medicine for treating liver cancer as well as preparation method and application thereof

A technology for the treatment of liver cancer and drugs, applied in the field of medicine, can solve the problems of insignificant curative effect, large side effects, high cost, etc., and achieve the effect of significant curative effect, low production cost and prolonging the survival period

Inactive Publication Date: 2017-03-15
ZHENGZHOU RENHONG PHARMA CO LTD
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

my country mainly relies on surgery, radiotherapy and chemotherapy in the treatment of liver cancer. However, while the above methods kill cancer cells, normal cells of the human body are also damaged. Western medicines with anti-cancer effects have large side effects, ineffective curative effects, and high cost. expensive
In most cases, traditional Chinese medicine can only play a controlling role in anti-cancer and cancer treatment. Although it can relieve the disease and pain, the curative effect is not good

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0018] In an embodiment of the present invention, a drug for treating liver cancer is composed of the following raw materials in parts by weight: 13 parts of digoxin, 15 parts of chlorogenic acid, 1 part of carvone, and 7 parts of catechin.

[0019] Mix digoxin and catechin, add 5.8 times the mass of deionized water, and conduct ultrasonic treatment at 48° C. for 22 minutes with an ultrasonic power of 900 W to prepare mixture A. Chlorogenic acid was mixed with mixture A, and subjected to microwave treatment for 8 minutes at a microwave power of 800W to prepare mixture B. Mix carvylone with mixture B, ultrasonicate at a temperature of 55°C for 15 minutes with an ultrasonic power of 700W, and stir at 60°C until dry to obtain the drug.

Embodiment 2

[0021] In an embodiment of the present invention, a drug for treating liver cancer is composed of the following raw materials in parts by weight: 21 parts of digoxin, 25 parts of chlorogenic acid, 5 parts of carvone, and 15 parts of catechin.

[0022] Mix digoxin and catechin, add 5.8 times the mass of deionized water, and conduct ultrasonic treatment at 48° C. for 22 minutes with an ultrasonic power of 900 W to prepare mixture A. Chlorogenic acid was mixed with mixture A, and subjected to microwave treatment for 8 minutes at a microwave power of 800W to prepare mixture B. Mix carvylone with mixture B, ultrasonicate at a temperature of 55°C for 15 minutes with an ultrasonic power of 700W, and stir at 60°C until dry to obtain the drug.

Embodiment 3

[0024] In an embodiment of the present invention, a drug for treating liver cancer is composed of the following raw materials in parts by weight: 15 parts of digoxin, 18 parts of chlorogenic acid, 2 parts of carvone, and 9 parts of catechin.

[0025] Mix digoxin and catechin, add 5.8 times the mass of deionized water, and conduct ultrasonic treatment at 48° C. for 22 minutes with an ultrasonic power of 900 W to prepare mixture A. Chlorogenic acid was mixed with mixture A, and subjected to microwave treatment for 8 minutes at a microwave power of 800W to prepare mixture B. Mix carvylone with mixture B, ultrasonicate at a temperature of 55°C for 15 minutes with an ultrasonic power of 700W, and stir at 60°C until dry to obtain the drug.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention discloses a medicine for treating liver cancer as well as a preparation method and application thereof. The medicine is prepared from the following raw materials in parts by weight: 13 to 21 parts of digoxin, 15 to 25 parts of chlorogenic acid, 1 to 5 parts of carvone and 7 to 15 parts of catechinic acid. The preparation method comprises the following steps: mixing the digoxin and the catechinic acid, then adding deionized water with the mass which is 5.8 times of the total mass of the digoxin and the catechinic acid, and performing ultrasonic treatment at the temperature of 48 DEG C for 22 minutes to prepare a mixture A; mixing the chlorogenic acid and the mixture A, and performing microwave treatment for 8 minutes to prepare a mixture B; mixing the carvone and the mixture B, performing ultrasonic treatment at the temperature of 55 DEG C for 15 minutes, and then stirring at the temperature of 60 DEG C until the mixture is dried, so as to obtain the medicine. The medicine is outstanding in liver cancer treating effect, safe and reliable, can reduce adverse reactions of chemotherapy, is favorable for timely relieving the symptom of a patient, and is relatively good in treating effect on the liver cancer. The preparation process is simple, and the used raw materials are simple and easy to access; the production cost is low; the medicine is easy to take, good in absorption effect, does not have a side effect and can prolong life, and is good in patient tolerance.

Description

technical field [0001] The invention relates to the technical field of medicine, in particular to a medicine for treating liver cancer and its preparation method and application. Background technique [0002] Liver cancer is a malignant tumor of the liver, which can be divided into two categories: primary and secondary. Primary malignant tumors of the liver originate from the epithelial or mesenchymal tissues of the liver. The former is called primary liver cancer, which is a malignant tumor with a high incidence in my country and is extremely harmful; rare. Liver cancer seriously threatens people's health and life, and is called "the king of cancer". The 5-year survival rate of patients with intermediate-stage liver cancer does not exceed 5%. Primary liver cancer mainly includes different pathological types such as hepatocellular carcinoma (HCC, accounting for more than 90%), intrahepatic cholangiocarcinoma (ICC) and mixed hepatocellular carcinoma-intrahepatic cholangioca...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/7048A61P35/00A61K31/216A61K31/122A61K31/353
CPCA61K31/7048A61K31/122A61K31/216A61K31/353A61K2300/00
Inventor 不公告发明人
Owner ZHENGZHOU RENHONG PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap